Generic Name: fostemsavir
Drug Class: Entry Inhibitors
Company: ViiV Healthcare
Approval Status: Experimental
Generic Version Available: No
Experimental Code: BMS-663068
Fostemsavir has not yet been reviewed for inclusion in the DHHS list of recommended HIV treatments.
Fostemsavir is an experimental HIV medication. It is in a category of HIV medicines called attachment inhibitors. It is currently in Phase III clinical trials. Fostemsavir targets a different step of the viral lifecycle and may be an option for indiviuals with virus that has become highly resistant to other HIV drugs.
Fostemsavir must be used in combination with other HIV drugs.
Last Reviewed: September 25, 2018